Scisparc submitted ind application to the fda for sci-110 phase iib clinical trial for patients with tourette syndrome

Scisparc to conduct the trial at the yale child study center at the yale school of medicine in the usa, hannover medical school in germany and tel aviv sourasky medical center in israel
SPRC Ratings Summary
SPRC Quant Ranking